132 related articles for article (PubMed ID: 36646528)
1. Differentiating between adult intracranial medulloblastoma and ependymoma using MRI.
Deng J; Xue C; Liu X; Li S; Zhou J
Clin Radiol; 2023 Mar; 78(3):e288-e293. PubMed ID: 36646528
[TBL] [Abstract][Full Text] [Related]
2. Application of Apparent Diffusion Coefficient Histogram Metrics for Differentiation of Pediatric Posterior Fossa Tumors : A Large Retrospective Study and Brief Review of Literature.
Gonçalves FG; Zandifar A; Ub Kim JD; Tierradentro-García LO; Ghosh A; Khrichenko D; Andronikou S; Vossough A
Clin Neuroradiol; 2022 Dec; 32(4):1097-1108. PubMed ID: 35674799
[TBL] [Abstract][Full Text] [Related]
3. Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki-67 Proliferation Index.
Xianwang L; Lei H; Hong L; Juan D; Shenglin L; Caiqiang X; Yan H; Junlin Z
J Neuroimaging; 2021 Jan; 31(1):132-136. PubMed ID: 32961009
[TBL] [Abstract][Full Text] [Related]
4. The impact of ADC-histogram parameters on the discrimina-tion between medulloblastoma, ependymoma, and pilocytic astrocytoma.
Minh Duc N
Clin Ter; 2022; 173(4):369-376. PubMed ID: 35857056
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Apparent Diffusion Coefficient in Pediatric Medulloblastoma, Ependymoma, and Pilocytic Astrocytoma.
Dury RJ; Lourdusamy A; Macarthur DC; Peet AC; Auer DP; Grundy RG; Dineen RA
J Magn Reson Imaging; 2022 Jul; 56(1):147-157. PubMed ID: 34842328
[TBL] [Abstract][Full Text] [Related]
6. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
Li X; Wang H; Gao J; Jiang L; Chen M
Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of apparent diffusion coefficient thresholds for diagnosis of medulloblastoma using diffusion-weighted imaging.
Pierce TT; Provenzale JM
Neuroradiol J; 2014 Feb; 27(1):63-74. PubMed ID: 24571835
[TBL] [Abstract][Full Text] [Related]
8. The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.
Gonçalves FG; Tierradentro-Garcia LO; Kim JDU; Zandifar A; Ghosh A; Viaene AN; Khrichenko D; Andronikou S; Vossough A
Pediatr Radiol; 2022 Dec; 52(13):2595-2609. PubMed ID: 35798974
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of Cerebellar Hemisphere Tumors: Combining Apparent Diffusion Coefficient Histogram Analysis and Structural MRI Features.
Payabvash S; Tihan T; Cha S
J Neuroimaging; 2018 Nov; 28(6):656-665. PubMed ID: 30066449
[TBL] [Abstract][Full Text] [Related]
10. Application of diffusion-weighted imaging combined with apparent diffusion coefficient in differential diagnosis between central neurocytoma and ependymoma.
Sun PF; Ma L; Ye BQ; Pei YY
Neuroradiology; 2020 Apr; 62(4):439-445. PubMed ID: 31853589
[TBL] [Abstract][Full Text] [Related]
11. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
[TBL] [Abstract][Full Text] [Related]
12. Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma.
He W; Xiao X; Li X; Guo Y; Guo L; Liu X; Xu Y; Zhou J; Wu Y
Eur J Radiol; 2019 Mar; 112():186-191. PubMed ID: 30777209
[TBL] [Abstract][Full Text] [Related]
13. The Role of Apparent Diffusion Coefficient in the Differentiation between Cerebellar Medulloblastoma and Brainstem Glioma.
Minh Thong P; Minh Duc N
Neurol Int; 2020 Oct; 12(3):34-40. PubMed ID: 33137983
[TBL] [Abstract][Full Text] [Related]
14. Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases.
Han C; Huang S; Guo J; Zhuang X; Han H
J Magn Reson Imaging; 2015 Jul; 42(1):80-6. PubMed ID: 25223489
[TBL] [Abstract][Full Text] [Related]
15. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.
Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z
Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213
[TBL] [Abstract][Full Text] [Related]
16. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from Brain Metastases in Posterior Fossa.
Onishi S; Hirose T; Takayasu T; Nosaka R; Kolakshyapati M; Saito T; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2017 May; 101():643-650. PubMed ID: 28179177
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
18. Diffusion MRI in Evaluation of Pediatric Posterior Fossa Tumors.
Phuttharak W; Wannasarnmetha M; Wara-Asawapati S; Yuthawong S
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1129-1136. PubMed ID: 33906305
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
Caravan I; Ciortea CA; Contis A; Lebovici A
Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
[TBL] [Abstract][Full Text] [Related]
20. Use of apparent diffusion coefficient values for diagnosis of pediatric posterior fossa tumors.
Pierce T; Kranz PG; Roth C; Leong D; Wei P; Provenzale JM
Neuroradiol J; 2014 Apr; 27(2):233-44. PubMed ID: 24750714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
